Richard T. George

Affiliation: Early Clinical Development Research and Early Development Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD
Institution: AstraZeneca
ORCID: 0000-0003-4817-0378
External IDs: ResearchGate: Richard_T_George | LinkedIn: richard-george
Email: richard.george@example.com
Works: 45, Cited by: 376, H-index: 12
Pharmacologist with a focus on cardiovascular research and drug development at AstraZeneca.

Education

  • PhD in Pharmacology, University of Maryland (2005-2009)
  • BS in Biochemistry, University of California, Berkeley (2001-2005)

Research Interests

Keywords:
Pharmacology Cardiovascular Research Drug Development
Topics:
Pharmacology Cardiovascular Research

Professional Links

Selected Publications

Lecithin shows promise for cholesterol management
George RT, Abuhatzira L, Stoughton SM, Karathanasis SK, She D, et al. MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High-Density Lipoprotein, and Low-Density Lipoprotein Receptor-Mediated Reverse Cholesterol Transport. J Am Heart Assoc. 2021;10:e014572. doi:10.1161/JAHA.119.014572
PubMed DOI
Effects of LCAT on cholesterol metabolism
Reyes-Soffer G, Matveyenko A, Lignos J, Matienzo N, Santos Baez LS, et al. Effects of Recombinant Human Lecithin Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans. Arterioscler Thromb Vasc Biol. 2024;44:1407. doi:10.1161/ATVBAHA.123.320387
PubMed DOI

Related Products